|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
-Opioid Receptors and Estrogen Receptor
: Anatomical Basis for Ovarian Sex Steroid Opioid AntinociceptionDepartment of Biochemistry, State University of New York, Downstate Medical Center, Brooklyn, New York (A.R.G., D.S.G., N.-J.L.) and Department of Neuroscience (S.A.S., M.W.W.), University of Minnesota, Minneapolis, Minnesota
Pharmacological and behavioral studies suggest that spinal
- and
-opioid antinociceptive systems are functionally associated with ovarian sex steroids. These interactions can be demonstrated specifically during pregnancy or hormone-simulated pregnancy (HSP). The analgesia associated with both conditions can be abolished by blockade of either spinal
-opioid receptors or
-opioid receptors (DOR). Furthermore, both dynorphin (DYN) release (J Pharmacol Exp Ther 298:1213–1220, 2001) and the processing of the DYN precursor (J Neurochem 65:1374–1380, 1995) are significantly increased in the spinal cord during HSP. We undertook the current study to determine whether DYN, DOR, and estrogen receptor
(ER
) share anatomical relationships that permit their direct interaction. Coexpression of DOR or ER
by DYN neurons was assessed using fluorescence immunohistochemistry and a synaptosomal release assay. Findings show that ER
and DYN are coexpressed. Moreover, in the spinal cord of HSP animals, there were significant increases in the number of DYN-immunoreactive (DYN-ir) cells, ER
-ir cells, cells double-labeled for DYN-ir and ER
-ir and the proportion of DYN-ir cells coexpressing ER
. Some varicose fibers in the spinal cord dorsal horn and intermediate gray matter that expressed DYN-ir also expressed DOR-ir. Activation of DORs located on DYN terminals was sufficient to inhibit K+-evoked DYN release. These data define, at least in part, the anatomical substrates that may be relevant to the antinociception of gestation and its hormonal simulation. Furthermore, they provide a framework for understanding sex-based nociception and antinociception and suggest novel strategies for treating pain.
Address correspondence to: Dr. Alan Gintzler, Box 8, Department of Biochemistry, SUNY Downstate Medical Center, 450 Clarkson Ave, Brooklyn, NY 11203. E-mail: alan.gintzler{at}downstate.edu